STADA Arzneimittel
 |
|
| Aktiengesellschaft | |
| Traded as | : SAZ |
| Industry | Pharmaceuticals |
| Founded | Dresden, 1895 |
| Headquarters | Bad Vilbel, Germany |
|
Key people
|
Dr. Matthias Wiedenfels (CEO and chairman of the executive board), Carl Ferdinand Oetker (Chairman of the supervisory board) |
| Products | Generic and over-the-counter drugs |
| Revenue | €2.06 billion (2014) |
| €188.5 million (2014) | |
| Profit | €64.6 million (2014) |
| Total assets | €3.335 billion (end 2014) |
| Total equity | €903.3 million (end 2014) |
|
Number of employees
|
10,363 (FTE, average 2014) |
| Website | www.stada.de |
Stada Arzneimittel AG is a pharmaceutical company based in Bad Vilbel, Germany which specializes in the production of generic and over-the-counter drugs. In 2014, revenue totaled €2.06 billion.
Commonly known products produced by Stada are Stada-brand acetaminophen and lactulose, Grippostad-C cold medicine and Ladival sun protection products. Stada- The Health Company is involved in various charity projects and sponsoring activities which include the support for dolphin aid e.V since 2007 and the support of a Romanian children's village in Timisoara.
Stada was founded in Dresden in 1895 as a cooperative pharmacy. Stada was originally an acronym for Standardarzneimittel Deutscher Apotheker (Standard Drugs (of) German Pharmacists). After World War II, the company was relocated to Essen and Tübingen. In 1956 it was moved again to Bad Vilbel and in 1970, Stada began trading on the stock exchange as a public company. At that time the shares were restricted to pharmacists as restrictedly transferable registered shares. Five years later, Stada entered the generic drug market.
In 1999 Stada's German subsidiary, NIDDApharm GmbH, entered the german generic drugs market - worth an estimated 300 million DM.
In September 2000, the company executed a 1:10 share split on the . In October the company entered into an agreement with Montenegro Group to acquire the pharmaceutical products of the "Bonomelli Farmazia" product line, rolling into the companies Italian subsidiary, EG S.p.A. – Laboratorie Eurogenerici.
In July 2001 the company acquired the American generic drug supplier MOVA Laboratories Inc.
In April 2002 the company acquired Spanish pharmaceutical company Bayvit S.A from Bayer and Vita S.A. Bayvit is the second-largest supplier of generic drugs in Spain, with recorded sales in 2000 of €20 million. In May, the company acquired Marketing and Sales Operations of the Italian pharmaceutical company Crinos SpA, rolling it into the Italian subsidiary EG SpA. In September the company established a joint venture in Brazil: Ava Stada Pharma Latin America Ltda, 51% owned by Stada and 49% owned by Brazilian company AVA Industrial S/A. In November of the same year, the company acquired an increase shareholding in Ciclum Farma S.A., from 50% to 74%, with Grünenthal GmbH taking over the remaining 26% of shares.
...
Wikipedia